| Tretinoin | Approved Investigational Nutraceutical | LAMA3 | 3909 |
upregulated | Tretinoin results in increased expression of LAMA3 mRNA | 18q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMA4 | 3910 |
upregulated | Tretinoin results in increased expression of LAMA4 mRNA | 6q21 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMA5 | 3911 |
upregulated | Tretinoin results in increased expression of LAMA5 mRNA | 20q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMB1 | 3912 |
upregulated | Tretinoin results in increased expression of LAMB1 mRNA | 7q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMB2 | 3913 |
upregulated | Tretinoin results in increased expression of LAMB2 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMC1 | 3915 |
downregulated | Tretinoin results in decreased expression of LAMC1 mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMC1 | 3915 |
upregulated | Tretinoin results in increased expression of LAMC1 mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMC2 | 3918 |
upregulated | Tretinoin results in increased expression of LAMC2 mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMC3 | 10319 |
upregulated | Tretinoin metabolite results in increased expression of LAMC3 mRNA | 9q34.12 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMC3 | 10319 |
upregulated | Tretinoin results in increased expression of LAMC3 mRNA | 9q34.12 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMP1 | 3916 |
upregulated | Tretinoin results in increased expression of LAMP1 mRNA | 13q34 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMP2 | 3920 |
upregulated | Tretinoin results in increased expression of LAMP2 mRNA | Xq24 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMP3 | 27074 |
upregulated | Tretinoin results in increased expression of LAMP3 mRNA | 3q27.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LAMP5 | 24141 |
downregulated | Tretinoin results in decreased expression of LAMP5 mRNA | 20p12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LAPTM4B | 55353 |
downregulated | Tretinoin results in decreased expression of LAPTM4B mRNA | 8q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LAPTM4B | 55353 |
upregulated | Tretinoin results in increased expression of LAPTM4B mRNA | 8q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LAPTM5 | 7805 |
downregulated | Tretinoin results in decreased expression of LAPTM5 mRNA | 1p35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LAPTM5 | 7805 |
upregulated | Tretinoin results in increased expression of LAPTM5 mRNA | 1p35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LARP6 | 55323 |
upregulated | Tretinoin results in increased expression of LARP6 mRNA | 15q23 | |
| Tretinoin | Approved Investigational Nutraceutical | LARP7 | 51574 |
downregulated | Tretinoin results in decreased expression of LARP7 mRNA | 4q25 | |
| Tretinoin | Approved Investigational Nutraceutical | LARS | 51520 |
downregulated | Tretinoin results in decreased expression of LARS mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | LASP1 | 3927 |
upregulated | Tretinoin results in increased expression of LASP1 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | LAT2 | 7462 |
downregulated | Tretinoin results in decreased expression of LAT2 mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | LAYN | 143903 |
upregulated | Tretinoin results in increased expression of LAYN mRNA | 11q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LBH | 81606 |
upregulated | Tretinoin results in increased expression of LBH mRNA | 2p23.1 | |